, Volume 3, Issue 4, pp 190-196
Date: 10 Jun 2010

Intracoronary Ultrasound in Assessing Efficacy of Cardiovascular Drugs

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Despite substantial advances in our approach to prevent cardiovascular disease, there is an ongoing need to develop new therapeutic strategies to achieve more effective reduction in cardiovascular risk. Intravascular ultrasound imaging of the coronary arteries has been increasingly employed in clinical trials to evaluate the impact of medical therapies on the progression of atherosclerosis. In addition to the ability to assess whether novel agents can slow disease progression, these studies have provided a number of important insights into the factors that underlie the natural history of disease progression.